Figure 2.
Consolidated Standards of Reporting Trials diagram. IHC, immunohistochemistry; WSG-ADAPT-TN, the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer - Triple Negative Breast Cancer trial.